These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38504059)

  • 1. Obesity-related glomerulopathy is associated with elevated WT1 expression in podocytes.
    Jakhotia S; Kavvuri R; Raviraj S; Baishya S; Pasupulati AK; Reddy GB
    Int J Obes (Lond); 2024 Aug; 48(8):1080-1091. PubMed ID: 38504059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGR3 reduces podocyte inflammatory damage in obesity related glomerulopathy by inhibiting the PRMT1
    Peng L; Sun X; Yi X; Wang Z; Chen K
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):349-358. PubMed ID: 38970508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of podocyte Notch mediates early Wt1 glomerulopathy.
    Asfahani RI; Tahoun MM; Miller-Hodges EV; Bellerby J; Virasami AK; Sampson RD; Moulding D; Sebire NJ; Hohenstein P; Scambler PJ; Waters AM
    Kidney Int; 2018 Apr; 93(4):903-920. PubMed ID: 29398135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of Connexin43 expression in a rat model of obesity-related glomerulopathy.
    Zhao Y; Li G; Wang Y; Liu Z
    Exp Mol Pathol; 2018 Feb; 104(1):12-18. PubMed ID: 29246788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Hypercaloric Diet Induces Early Podocyte Damage in Aged, Non-Diabetic Rats.
    Seikrit C; Lausberg E; Buhl EM; Gaspar R; Tabi T; Heffer M; Ducza E; Sztojkov-Ivanov A; Seres AB; Szucs K; Ivic V; Floege J; Vari SG; Boor P; Klinkhammer BM
    Cell Physiol Biochem; 2021 Dec; 55(S4):96-112. PubMed ID: 34936286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1 analog prevents obesity-related glomerulopathy by inhibiting excessive autophagy in podocytes.
    Guo H; Wang B; Li H; Ling L; Niu J; Gu Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F181-F189. PubMed ID: 29070572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
    Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
    FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocytes play an etiological role in the podocytopathy of high-fat diet-fed rats.
    Chen JY; Jian DY; Lien CC; Lin YT; Ting CH; Chen LK; Hsu TC; Huang HM; Wu YT; Kuan TT; Chao YW; Wu LY; Huang SW; Juan CC
    J Endocrinol; 2016 Nov; 231(2):109-120. PubMed ID: 27539963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
    Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
    Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global polysome analysis of normal and injured podocytes.
    Okabe M; Motojima M; Miyazaki Y; Pastan I; Yokoo T; Matsusaka T
    Am J Physiol Renal Physiol; 2019 Feb; 316(2):F241-F252. PubMed ID: 30379099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
    Jing Z; Wei-jie Y; Yi-Feng ZG
    Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.
    Xu X; Huang X; Zhang L; Huang X; Qin Z; Hua F
    BMC Nephrol; 2021 Jun; 22(1):218. PubMed ID: 34107901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
    Sakairi T; Abe Y; Kopp JB
    Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1.
    Li TS; Chen L; Wang SC; Yang YZ; Xu HJ; Gu HM; Zhao XJ; Dong P; Pan Y; Shang ZQ; Zhang XQ; Kong LD
    Biochem Pharmacol; 2019 Aug; 166():139-152. PubMed ID: 31085161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible ATF3-NFAT axis aggravates podocyte injury.
    Zhang H; Liang S; Du Y; Li R; He C; Wang W; Liu S; Ye Z; Liang X; Shi W; Zhang B
    J Mol Med (Berl); 2018 Jan; 96(1):53-64. PubMed ID: 29038896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte-specific deletion of tubular sclerosis complex 2 promotes focal segmental glomerulosclerosis and progressive renal failure.
    Iwata W; Unoki-Kubota H; Kato H; Shimizu A; Matsumoto M; Imasawa T; Igarashi A; Matsumoto K; Noda T; Terauchi Y; Nangaku M; Kasuga M; Kaburagi Y
    PLoS One; 2020; 15(3):e0229397. PubMed ID: 32191726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
    Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
    Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis.
    Petrakis I; Mavroeidi V; Stylianou K; Andronikidi E; Lioudaki E; Perakis K; Stratigis S; Vardaki E; Zafeiri M; Giannakakis K; Plaitakis A; Amoiridis G; Saraiva MJ; Daphnis E
    Amyloid; 2013 Sep; 20(3):164-72. PubMed ID: 23829269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.